Retatrutide is an investigational triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously, with Phase 2 trials using once-weekly subcutaneous doses of 1 mg to 12 mg
Adaptation tip: Smaller, simpler meals (and slower eating) may help reduce discomfort during the initial adjustment phase
During a White House press briefing Tuesday, Dr
How can I avoid scams like this in the future
Most likely what you're going to be doing is giving yourself more expensive urine. Dietary supplements should not be used as an alternative to a prescription drug, and their manufacturers cant claim to deliver the same outcomes as FDA-approved GLP-1 medications like Wegovy or Zepbound, Ventura notes
However, prolonged exposure to GLP-1RAs can lead to tachyphylaxis, reducing their effect on gastric emptying over time